ITonis

ITNS · OTC

$0.0005+$0.00 (+0.00%)TodayMarket closed · Oct 20, 1:15 PM ET

Prev close $0.0005

About ITNS

Itonis, Inc. engages in the distribution of its homeopathic anti-nausea product to the medical and pharmaceutical industry. The company is headquartered in Lake Forest, California. The company went IPO on 2007-02-21. The Company’s Pharmaceuticals division to produce and market over the counter and prescription homeopathic preparations to treat both common ailments and chronic diseases. The firm has launched the retails sale of the Emesyl nausea relief product. The firm has identified the market for its Emesyl product line as the general public who suffers from nausea. Emesyl has been available for purchase at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com. Its subsidiaries include Itonis Holdings, Inc., Itonis Pharmaceuticals, and Paramount Discoveries, Inc.

Employees: 3
Headquarters: Lake Forest, California
Listed: Feb 21, 2007
Sector: Health Care
Industry: Pharmaceuticals
Website: itonisholdings.com

Leadership

ITonis executives
Name	Title	Since	Age
Thomas Roberts	—	—	42
Lawrence Haber	—	—	53
Antonin Kral	—	2006	31
Iain Fidlin	—	—	51

Similar companies

Companies in the same industry as ITonis

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.